Utah Medical Products (NASDAQ:UTMD) Issues Earnings Results

Utah Medical Products (NASDAQ:UTMD) released its quarterly earnings data on Tuesday. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter, Zacks reports. Utah Medical Products had a net margin of 34.62% and a return on equity of 12.10%.

Utah Medical Products Price Performance

Shares of NASDAQ UTMD traded down $0.65 during midday trading on Tuesday, reaching $63.53. 7,750 shares of the stock traded hands, compared to its average volume of 20,129. The company’s 50 day moving average is $62.86 and its 200 day moving average is $65.66. Utah Medical Products has a one year low of $60.08 and a one year high of $83.05. The stock has a market capitalization of $215.35 million, a PE ratio of 14.88 and a beta of 0.09.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Stockholders of record on Monday, December 16th were issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 1.92%. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date was Monday, December 16th. Utah Medical Products’s dividend payout ratio is 28.57%.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.